RVTY:NYSE
Revvity Inc
$86.77
arrow_downward
-0.44%(-0.38) 1 日
$86.77
0.00% (0.00)
bedtime時間外取引
終了: 4月24日, 16:00:05 GMT-4 · USD
search
すべての記号
1 日
5 日
1 か月
6 か月
年初来
1 年
5 年
最大
| 記号 | 価格 | 変化 | 変化率 |
|---|
insights_autoRVTY の上位の分析情報を生成しています...
始値
$87.27
高値
$88.12
安値
$85.58
時価総額
97.01億
平均出来高
96.28万
取引量
124.81万
52 週高値
$118.30
52 週安値
$81.36
ベータ版
1.13
発行済株式数
1.12億
従業員数
1万
ニュース記事
ウェブの情報から
プロフィール
Revvity, Inc. is an American company in the life sciences and diagnostics business that is focused on selling to the pharmaceutical and biotechnology industries, especially in relation to approaches making use of new cell therapy or gene therapy developments. Its origins lie with the long-existing company PerkinElmer, which has been in a variety of business lines.
In 2022, a split of PerkinElmer resulted in one part, comprising its applied, food and enterprise services businesses, being sold to the private equity firm New Mountain Capital for $2.45 billion and thus no longer being public but keeping the PerkinElmer name. The other part, comprising the life sciences and diagnostics businesses, remained public but required a new name, which in 2023 was announced as Revvity, Inc. From the perspective of Revvity, the goal of creating a separate company was that its businesses might show greater profit margins and more in the way of growth potential. An associated goal was to have more financial flexibility moving forward. On May 16, 2023, the PerkinElmer stock symbol PKI was replaced by the new symbol RVTY. Wikipedia
Revvity Inc について